America's Got Talent Winner Paul Zerdin to Perform at Four

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
America's Got Talent Winner Paul Zerdin to Perform at Four Winds New Buffalo on Friday March 4 2016

NEW BUFFALO, MI--(Marketwired - Nov 12, 2015) - The Pokagon Band of Potawatomi Indians' Four Winds New Buffalo® is pleased to announce a performance by comedian and ventriloquist Paul Zerdin at its Silver Creek Event Center on Friday, March 4, 2016 at 9 p.m. Paul recently was voted as the winner of the 10th season of NBC's "America's Got Talent." Tickets can be purchased beginning on Friday, November 13 at 10 a.m. Eastern exclusively through the Ticketmaster® Web site, www.ticketmaster.com , or by calling (800)745-3000. Ticket prices for the performance start at $50 plus applicable fees.

Four Winds New Buffalo will be offering hotel and dinner packages along with tickets to the performance by Paul Zerdin. The Hard Rock option is available for $369 and includes two concert tickets, a one night hotel stay on Friday, March 4, and a $50 gift card to Hard Rock Cafe Four Winds. The Copper Rock option is available for $469 and includes two concert tickets, a one night hotel stay on Friday, March 4, and a $150 gift card to Copper Rock Steakhouse. All dinner and hotel packages must be purchased through Ticketmaster.

In September 2015, Paul Zerdin impressed audiences with his ventriloquism skills and comedic puppet characters to win the latest season of NBC's "America's Got Talent." Paul has spent years taking the art of ventriloquism to new heights. When he was 10 years old, a family friend made him a puppet theater, which he used to put on shows. Later, he was given a book on ventriloquism written by the legendary Ray Alan. His hobby became an obsession and soon a career. From Royal Variety performances to comedy festivals around the globe, Paul is constantly breaking new ground, all of which has established him at the forefront of his profession. More information about Paul is available at www.paulzerdin.com .

Four Winds New Buffalo's Silver Creek Event Center is a 1,500 seat, multi-use facility that is located next to the casino floor. In addition to hosting concerts, the 17,000 sq. ft. event center can be reconfigured to host a variety of meetings, special events, conferences, and banquets. Details on concerts at Silver Creek Event Center are available at www.fourwindscasino.com/events .

Reservations and Information To make a hotel reservation at Four Winds New Buffalo or for more information on Four Winds New Buffalo, Four Winds Hartford®, or Four Winds Dowagiac®, please call 1 (866)-4WINDS1, (866)494-6371 or visit www.fourwindscasino.com . Additionally, be sure to like Four Winds on Facebook at www.facebook.com/fourwindscasino and follow on Twitter at www.twitter.com/fourwindscasino for information on the latest offers and promotions.

Media Contacts: Joshua Taustein Dresner Corporate Services (312)780-7219 jtaustein@dresnerco.com David Gutierrez Dresner Corporate Services (312)780-7204 dgutierrez@dresnerco.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Cottage Grove Tests Holiday Demand Across Lake Norman

Updated Category News Views 125

Flour and foot traffic make a pretty honest little scoreboard. Cottage Grove Bakery is putting itself in front of Lake Norman shoppers twice on Saturday, November 21, while also taking Thanksgiving orders and laying groundwork for 2027 workplace and school visits. This is not a public-company earnings story, and nobody should pretend a tray of scones is a quarterly...

Continue Reading
PexarBolt's CES Honor Meets a Real Crowdfunding Test

Updated Category News Views 77

A little touchscreen bolted onto a dock would usually make me roll my eyes. This time, Pexar has at least put enough muscle behind the gimmick to deserve a harder look. The PexarBolt Ultra TBT5 Dock was named a CES Innovation Awards 2027 Honoree in Computer Peripherals & Accessories, following an IFA 2026 Innovation Awards honor only two months after its launch. Awards do...

Continue Reading
Tessera Delisting Leaves HLSQ in a Tougher Market Ahead

Updated Category News Views 116

November delivered a nasty little truth serum for Tessera Defense and Homeland Security: exchange status is not a cosmetic detail when the stock’s selling price has collapsed. On November 10, NYSE Regulation suspended trading in the company’s common shares on NYSE American and began delisting proceedings. By November 17, Tessera had a chance to request review by the...

Continue Reading
Six LIFE Photographers Bring History Into Florida Focus

Updated Category News Views 72

Seventy photographs can make a pretty loud argument when the historical record has been this lopsided. The Ashley Gibson Barnett Museum of Art at Florida Southern College has brought LIFE: Six Women Photographers to Lakeland, and it deserves more than the usual polite nod given to a traveling museum show. Open since November 14, 2026, and running through March 7, 2027,...

Continue Reading
Simmons Clarifies Texas Loan Exposure, But Risks Remain

Updated Category News Views 87

A $45 million discrepancy is not a rounding error, and Simmons First National has every reason to swat it down hard. The bank says recent reporting overstated financing tied to a Texas multifamily development at $133 million. Its stated total is roughly $88 million, with about $44 million participated to another financial institution. For shareholders in NASDAQ:SFNC, that...

Continue Reading
Greenberg Traurig Adds Privacy Muscle in Denver Office

Updated Category News Views 162

Privacy work used to be the legal department's back-room plumbing; now it can jam an entire product launch. That is why Greenberg Traurig's decision to bring Amber Mednick in as of counsel in Denver deserves more attention than the usual law-firm hiring blurb. This is not a splashy deal, and nobody should pretend one lateral hire rewrites the competitive map. Still, it is...

Continue Reading
Sitting, Lymph Flow, and a Supplement Maker's Pitch

Updated Category News Views 32

By late afternoon, a chair can feel like it has quietly won the argument against your legs. PureHealth Research is leaning into that familiar heavy, puffy-legged feeling with a reminder about lymphatic flow—and, naturally, an eight-ingredient supplement positioned alongside it. The broad message is sensible. The sales layer needs the usual healthy squint. Movement Does...

Continue Reading
OU's $44.3M Rural Care Plan Targets Oklahoma Care Gaps

Updated Category News Views 100

A Long Drive Is a Brutal Barrier to Care Seventy-five of Oklahoma's 77 counties sit in health professional shortage territory, a figure that ought to stop people cold. It means at least 3,500 patients per provider in those counties. That is not some abstract planning headache. It is the pregnant patient delaying a specialist visit, the family weighing an ambulance ride,...

Continue Reading
Faex Health Adds Ebola and H. pylori AI Screening Tools

Updated Category News Views 82

A smartphone pointed at a toilet is an awkward place to hunt for medical progress, yet Faex Health is making a serious attempt to turn that daily evidence into an early-warning tool. The company has added investigational pre-screening capabilities for Ebola virus disease and Helicobacter pylori, or H. pylori, bringing its internally validated panel to 18 gastrointestinal...

Continue Reading
Fluence Investors Face a November 27 Litigation Clock

Updated Category News Views 40

Six calendar squares are all that separate eligible Fluence investors from the November 27, 2026 lead-plaintiff deadline. That is not much time to locate trade confirmations, calculate losses, and decide whether taking a larger role in a securities case makes sense. The lawsuit is not a verdict, and anybody pretending otherwise is selling smoke. But the underlying...

Continue Reading

Top 5 Most Recently Viewed Articles

Significant Unusual Options Activity Signals Opportunity in GOOGL

Updated Category News Views 97

Analyzing Recent Options Activity for Alphabet Currently, investors are exhibiting a strong bullish sentiment towards Alphabet (NASDAQ: GOOGL), a trend that is capturing the attention of market participants. Recent observations of public options have revealed significant movements in GOOGL, hinting at potential changes ahead. Recent analyses have uncovered 129 unusual...

Continue Reading
Encore and UKG Introduce Innovative Overtime Savings Program

Updated Category News Views 298

Encore and UKG Join Forces for Employee Financial Wellness Encore, a prominent global leader in event technology and production services, has unveiled an innovative ‘Overtime Savings Program’ in collaboration with UKG, a top provider of HR and workforce management solutions. This remarkable initiative aims to empower Encore's frontline workers, allowing them to save...

Continue Reading
Discover Incredible Returns from Texas Pacific Land Investments

Updated Category News Views 160

The Incredible Growth of Texas Pacific Land Corp Texas Pacific Land Corp (NYSE: TPL) has marked its presence in the market with an outstanding performance over the past 15 years. The company has outshone the market median by an impressive 32.71% annually, which translates to a staggering average annual return of 45.46%. With a current market capitalization nearing $20.51...

Continue Reading
Cypherpunk Q2 2026: Zcash Growth Sparks Market Buzz

Updated Category News Views 76

Cypherpunk Technologies' Stellar Q2 Performance Sit tight, folks, because Cypherpunk Technologies just unleashed a financial update that's got the market buzzing. They've reported a staggering net income of $39.4 million for Q2 2026, quite the turnaround from a $16.6 million loss in the same quarter last year. It's a serious win, no doubt pumped up by their fruitful Zcash...

Continue Reading
Exciting Findings from Aicuris’ Clinical Trials of AIC468

Updated Category News Views 182

Encouraging Insights into AIC468 from Clinical Trials Recently, a notable advancement in medical research has emerged from Aicuris Anti-infective Cures AG regarding its novel treatment, AIC468. This drug is an innovative antisense oligonucleotide targeting the BK virus, particularly in kidney transplant recipients. The first-in-human (FIH) Phase 1 trial has provided...

Continue Reading